Metabolic biomarkers for preventive molecular medicine
A team of scientists from the Spanish National Cancer Research Centre, led by its director, María Blasco, together with Jose M. Mato, the director of the Center for Cooperative Research in Biosciences, has shown that the ...
Medical research
Dec 04, 2012 |
not rated yet |
0
Researchers find new target for Alzheimer's drug development
Researchers at the University of Minnesota's Center for Drug Design have developed a synthetic compound that, in a mouse model, successfully prevents the neurodegeneration associated with Alzheimer's disease.
Alzheimer's disease & dementia
Dec 03, 2012 |
5 / 5 (1) |
0
|
New risk factor identified for high blood pressure during pregnancy
Preeclampsia is a serious complication of pregnancy and the major cause of death for both mother and child in Europe and the U.S. It affects about one in 20 pregnancies. The main symptoms are high blood pressure and protein ...
Medical research
Nov 26, 2012 |
not rated yet |
0
Study finds high exposure to food-borne toxins
In a sobering study published in the journal Environmental Health, researchers at UC Davis and UCLA measured food-borne toxin exposure in children and adults by pinpointing foods with high levels of toxic compounds and de ...
Health
Nov 13, 2012 |
5 / 5 (1) |
0
|
Researchers identify novel metabolic programs driving aggressive brain tumors
Researchers at Moffitt Cancer Center have identified metabolic signatures that may pave the way for personalized therapy in glioma, a type of tumor that starts in the brain.
Cancer
Nov 09, 2012 |
4 / 5 (1) |
0
|
Global metabolomic initiative announced: Scientists set sail on the uncharted waters of the metabolome
Investigators at Washington University and The Scripps Research Institute have announced the launch of a "Global Metabolomic Initiative" to facilitate meta-analyses on studies of the metabolism of bacteria, ...
Other
Nov 07, 2012 |
not rated yet |
0
Mice with 'humanized' livers improve early drug testing
Stanford University School of Medicine scientists have used bioengineered mice with livers composed largely of human cells to characterize a drug about to enter early-stage clinical development for combating hepatitis C.
Medical research
Oct 31, 2012 |
3 / 5 (1) |
0
|
Insulin glargine's main metabolic effect as metabolite M1
(HealthDay)—For patients with type 2 diabetes, following administration of a subcutaneous injection of a therapeutic dose of insulin glargine, glargine is minimally detectable in blood, and most of the ...
Diabetes
Oct 25, 2012 |
not rated yet |
0
New model to explain the role of dopamine in immune regulation described
Dopamine is a neurotransmitter that is associated with emotions, movement, and the brain's pleasure and reward system. In the current issue of Advances in Neuroimmune Biology, investigators provide a broad overview of the ...
Immunology
Oct 11, 2012 |
5 / 5 (1) |
0
|
Team finds 14 new biomarkers for type 2 diabetes
A research team led by Anna Floegel of the German Institute of Human Nutrition (DIfE) and Tobias Pischon of the Max Delbrueck Center for Molecular Medicine (MDC) has identified 14 novel biomarkers for type ...
Diabetes
Oct 04, 2012 |
5 / 5 (1) |
0
Physiological role of a novel hormone FNDC5/irisin revealed in humans
A research team led by Dr. Christos Mantzoros, MD, PhD, at Beth Israel Deaconess Medical Center, Harvard Medical School, has published new findings elucidating the molecular and clinical role of FNDC5/irisin in humans.
Medical research
Oct 01, 2012 |
not rated yet |
0
Popular HIV drug may cause memory declines
The way the body metabolizes a commonly prescribed anti-retroviral drug that is used long term by patients infected with HIV may contribute to cognitive impairment by damaging nerve cells, a new Johns Hopkins research suggests.
HIV & AIDS
Sep 27, 2012 |
5 / 5 (1) |
0
|
Spring is the season for vitamin D deficiency, Australian study shows
September marks the start of spring but new research reveals it is also the month when Australians' vitamin D levels are at their lowest ebb.
Health
Sep 25, 2012 |
not rated yet |
0
Mathematical modelling to tackle metabolic diseases
Predictive mathematical models of signalling pathways are powerful biological tools that could be used for drug development. Using a similar approach, European scientists developed a computational model for ...
Medical research
Aug 30, 2012 |
not rated yet |
0
Developing novel biomarkers to predict Alzheimer's disease
Scientists from VTT Technical Research Centre of Finland in collaboration with the University of Eastern Finland have recently discovered a serum biochemical signature which predicts progression to Alzheimer's disease months ...
Alzheimer's disease & dementia
Jun 26, 2012 |
not rated yet |
0
